Xylooligosaccharide supplementation alters gut bacteria in both healthy and prediabetic adults: A pilot study

Frontiers in Physiology

Volumn 6, Issue Aug, 2015, Pages

  Yang, Jieping ^a   Summanen, Paula H ^b   Henning, Susanne M ^a   Hsu, Mark ^a   Lam, Heiman ^a   Huang, Jianjun ^a   Tseng, Chi Hong ^c   Dowd, Scot E ^d   Finegold, Sydney M ^e   Heber, David ^a   Li, Zhaoping ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MR DNA (Molecular Research LP)   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes; Gut; Microbiota; Prediabetic; Xylooligosaccharide

Indexed keywords

INSULIN; PLACEBO; PREBIOTIC AGENT; UNCLASSIFIED DRUG; XYLOOLIGOSACCHARIDE;

ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIUM; BACTERIUM IDENTIFICATION; BLAUTIA; BLAUTIA HYDROGENOTROPHICA; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; ENTERORHABDUS; FECES ANALYSIS; FEMALE; GENUS; GROWTH INHIBITION; HOWARDELLA; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INTESTINE FLORA; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PHYLUM; PILOT STUDY; POPULATION ABUNDANCE; RANDOMIZED CONTROLLED TRIAL; SLACKIA; TREATMENT DURATION;

EID: 84940834285     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00216     Document Type: Article

References (40)

1. Aachary, A. A., and Prapulla, S. G. (2011). Xylooligosaccharides (XOS) as an emerging prebiotic: microbial synthesis, utilization, structural characterization, bioactive properties, and applications. Compr. Rev. Food Sci. Food Saf. 10, 2-16. doi: 10.1111/j.1541-4337.2010.00135.x
2. Allard, P., Delvin, E. E., Paradis, G., Hanley, J. A., O'Loughlin, J., Lavallée, C., et al. (2003). Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. Clin. Chem. 49, 644-649. doi: 10.1373/49.4.644
3. Alles, M. S., de Roos, N. M., Bakx, J. C., van de Lisdonk, E., Zock, P. L., and Hautvast, G. A. (1999). Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes. Am. J. Clin. Nutr. 69, 64-69.
4. Amar, J., Chabo, C., Waget, A., Klopp, P., Vachoux, C., Bermúdez-Humarán, L. G., et al. (2011). Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol. Med. 3, 559-572. doi: 10.1002/emmm.201100159
5. American Diabetes Association. (2014). Standards of medical care in diabetes-2014. Diabetes Care 37(Suppl. 1), S14-S80. doi: 10.2337/dc14-S014
6. Baumgartner, A., Thurnheer, T., Lüthi-Schaller, H., Gmür, R., and Belibasakis, G. N. (2012). The phylum Synergistetes in gingivitis and necrotizing ulcerative gingivitis. J. Med. Microbiol. 61(Pt 11), 1600-1609. doi: 10.1099/jmm.0.047456-0
7. Campbell, J. M., Fahey, G. C. Jr., and Wolf, B. W. (1997). Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J. Nutr. 127, 130-136.
8. Cani, P. D., Neyrinck, A. M., Fava, F., Knauf, C., Burcelin, R. G., Tuohy, K. M., et al. (2007). Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374-2383. doi: 10.1007/s00125-007-0791-0
9. Chassaing, B., and Gewirtz, A. T. (2014). Gut microbiota, low-grade inflammation, and metabolic syndrome. Toxicol. Pathol. 42, 49-53. doi: 10.1177/0192623313508481
10. Choi, N., and Shin, H. S. (2006). Effect of oligosaccharides and inulin on the growth and viability of bifidobacteria in skim milk. Food Sci. Biotechnol. 15, 543-548.
11. Chung, Y. C., Hsu, C. K., Ko, C. Y., and Chan, Y. C. (2007). Dietary intake of xylooligosaccharides improves the intestinal microbiota, fecal moisture, and pH value in the elderly. Nutr. Res. 27, 756-761. doi: 10.1016/j.nutres.2007.09.014
12. DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., et al. (2006). Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72, 5069-5072. doi: 10.1128/AEM.03006-05
13. Dutta, D., Choudhuri, S., Mondal, S. A., Maisnam, I., Reza, A. H., Ghosh, S., et al. (2013). Tumor necrosis factor alpha -238G/A (rs 361525) gene polymorphism predicts progression to type-2 diabetes in an Eastern Indian population with prediabetes. Diab. Res. Clin. Pract. 99, e37-e41. doi: 10.1016/j.diabres.2012.12.007
14. Esteve, E., Ricart, W., and Fernández-Real, J. M. (2011). Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance? Curr. Opin. Clin. Nutr. Metab. Care 14, 483-490. doi: 10.1097/mco.0b013e328348c06d
15. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., et al. (2013). Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U.S.A. 110, 9066-9071. doi: 10.1073/pnas.1219451110
16. Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G. G., Neyrinck, A. M., et al. (2011). Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60, 2775-2786. doi: 10.2337/db11-0227
17. Finegold, S. M., Li, Z., Summanen, P. H., Downes, J., Thames, G., Corbett, K., et al. (2014). Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota. Food Funct. 5, 436-445. doi: 10.1039/c3fo60348b
18. Gobinath, D., Madhu, A. N., Prashant, G., Srinivasan, K., and Prapulla, S. G. (2010). Beneficial effect of xylo-oligosaccharides and fructo-oligosaccharides in streptozotocin-induced diabetic rats. Br. J. Nutr. 104, 40-47. doi: 10.1017/S0007114510000243
19. Goyal, R., Faizy, A. F., Siddiqui, S. S., and Singhai, M. (2012). Evaluation of TNF-alpha and IL-6 levels in obese and non-obese diabetics: pre- and postinsulin effects. N. Am. J. Med. Sci. 4, 180-184. doi: 10.4103/1947-2714.94944
20. Hooda, S., Boler, B. M. V., Serao, M. C. R., Brulc, J. M., Staeger, M. A., Boileau, T. W., et al. (2012). 454 pyrosequencing reveals a shift in fecal microbiota of healthy adult men consuming polydextrose or soluble corn fiber. J. Nutr. 142, 1259-1265. doi: 10.3945/jn.112.158766
21. International Scientific Association for Probiotics Prebiotics. (2004). Probiotics, prebiotics, and new foods. Proceedings of the 2nd annual meeting. Rome, Italy, September 7-9, 2003. J. Clin. Gastroenterol. 38(6 Suppl.), S60-S129.
22. Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., et al. (2011). Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 60, 631-637. doi: 10.1136/gut.2010.223263
23. Kang, D. W., Park, J. G., Ilhan, Z. E., Wallstrom, G., Labaer, J., Adams, J. B., et al. (2013). Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS ONE 8:e68322. doi: 10.1371/journal.pone.0068322
24. Kim, K. S., Rowlinson, M. C., Bennion, R., Liu, C., Talan, D., Summanen, P., et al. (2010). Characterization of Slackia exigua isolated from human wound infections, including abscesses of intestinal origin. J. Clin. Microbiol. 48, 1070-1075. doi: 10.1128/JCM.01576-09
25. Larsen, N., Vogensen, F. K., van den Berg, F. W., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., et al. (2010). Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 5:e9085. doi: 10.1371/journal.pone.0009085
26. Marotti, I., Bregola, V., Aloisio, I., Di Gioia, D., Bosi, S., Di Silvestro, R., et al. (2012). Prebiotic effect of soluble fibres from modern and old durum-type wheat varieties on Lactobacillus and Bifidobacterium strains. J. Sci. Food Agric. 92, 2133-2140. doi: 10.1002/jsfa.5597
27. Martínez, I., Lattimer, J. M., Hubach, K. L., Case, J. A., Yang, J., Weber, C. G., et al. (2013). Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J. 7, 269-280. doi: 10.1038/ismej.2012.104
28. Musso, G., Gambino, R., and Cassader, M. (2011). Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu. Rev. Med. 62, 361-80. doi: 10.1146/annurev-med-012510-175505
29. Plieskatt, J. L., Deenonpoe, R., Mulvenna, J. P., Krause, L., Sripa, B., Bethony, J. M., et al. (2013). Infection with the carcinogenic liver fluke Opisthorchis viverrini modifies intestinal and biliary microbiome. Faseb J. 27, 4572-84. doi: 10.1096/fj.13-232751
30. Portero McLellan, K. C., Wyne, K., Villagomez, E. T., and Hsueh, W. A. (2014). Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus. Ther. Clin. Risk Manag. 10, 173-188. doi: 10.2147/TCRM.S39564
31. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., et al. (2012). A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60. doi: 10.1038/nature11450
32. Remely, M., Dworzak, S., Hippe, B., Zwielehner, J., Aumüller, E., Brath, H., et al. (2013). Abundance and diversity of microbiota in type 2 diabetes and obesity. J. Diab. Metab. 4:253. doi: 10.4172/2155-6156.1000253
33. Rocas, I. N., and Siqueira, J. F. Jr. (2006). Characterization of Dialister species in infected root canals. J. Endod. 32, 1057-1061. doi: 10.1016/j.joen.2006.04.010
34. Rossi, M., Corradini, C., Amaretti, A., Nicolini, M., Pompei, A., Zanoni, S., et al. (2005). Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Appl. Environ. Microbiol. 71, 6150-6158. doi: 10.1128/AEM.71.10.6150-6158.2005
35. Shen, J., Obin, M. S., and Zhao, L. (2013). The gut microbiota, obesity and insulin resistance. Mol. Aspects Med. 34, 39-58. doi: 10.1016/j.mam.2012.11.001
36. Sheu, W. H., Lee, I. T., Chen, W., and Chan, Y. C. (2008). Effects of xylooligosaccharides in type 2 diabetes mellitus. J. Nutr. Sci. Vitaminol. (Tokyo) 54, 396-401. doi: 10.3177/jnsv.54.396
37. Tims, S., Derom, C., Jonkers, D. M., Vlietinck, R., Saris, W. H., Kleerebezem, M., et al. (2013). Microbiota conservation and BMI signatures in adult monozygotic twins. ISME J. 7, 707-717. doi: 10.1038/ismej.2012.146
38. Vartoukian, S. R., Palmer, R. M., and Wade, W. G. (2007). The division "Synergistes". Anaerobe 13, 99-106. doi: 10.1016/j.anaerobe.2007.05.004
39. Yamashita, K., Kawai, K., and Itakura, M. (1984). Effects of fructo-oligosaccharides on blood-glucose and serum-lipids in diabetic subjects. Nutr. Res. 4, 961-966. doi: 10.1016/S0271-5317(84)80075-5
40. Zhang, X., Shen, D., Fang, Z., Jie, Z., Qiu, X., Zhang, C., et al. (2013). Human gut microbiota changes reveal the progression of glucose intolerance. PLoS ONE 8:e71108. doi: 10.1371/journal.pone.0071108